aspirin has been researched along with Heart Valve Diseases in 76 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "When myocardial infarction is due to coronary embolism from endocarditic valves standard thrombolysis regimes should be avoided." | 5.29 | Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report. ( Connolly, DL; Crowley, JJ; Dardas, PS; Kenny, A; Petch, MC, 1994) |
| "Five previously suspected risk factors (valve surgery, prior protamine exposure, history of pulmonary hypertension, fish allergy, and vasectomy), aspirin ingestion within 7 days of surgery, and demographic information were recorded." | 5.10 | Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction. ( Comunale, ME; Haering, JM; Lowenstein, E; Mashikian, JS; Maslow, A; Robertson, LK, 2003) |
| "Plasma anticoagulation with warfarin during the early postoperative phase was shown statistically to be inferior to platelet aggregation inhibition by aspirin with regards to postoperative bleeding risk, cerebral ischemic events, and survival." | 3.83 | Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen? ( Breuer, M; Fuchs, J; Hüter, L; Kuntze, T; Lauer, B; Owais, T; Rouman, M, 2016) |
| " In patients with patent foramen ovale (PFO) and stroke or transient ischemic attack, we recommend initial aspirin therapy (Grade 1B) and suggest substitution of VKA if recurrence (Grade 2C)." | 3.78 | Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. ( Fremes, SE; Rubens, FD; Sun, JC; Teoh, KH; Whitlock, RP, 2012) |
| "This prospective audit reports pregnancy outcomes, anticoagulation complications, and anti-Xa levels in women with mechanical heart valves who were treated with therapeutic enoxaparin plus aspirin during pregnancy." | 3.71 | Enoxaparin treatment in women with mechanical heart valves during pregnancy. ( McCowan, LM; North, RA; Raudkivi, PJ; Rowan, JA, 2001) |
| "The risk of early recurrence of embolism in the first 30 days ranges from 8 to 15%." | 2.38 | [Embolic complications of chronic atrial fibrillation]. ( Brechenmacher, C; Chauvin, M; Koenig, A; Théolade, R, 1992) |
| "Minor bleedings were observed in 19 (17." | 1.91 | [Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions]. ( Berdibekov, BS; Bulaeva, NI; Golukhova, EZ; Kubova, MC; Ruzina, EV, 2023) |
| "Aspirin has been shown to decrease postoperative CABG mortality and ischemic events." | 1.38 | Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery. ( Blackstone, E; Cho, L; Jacob, M; Smedira, N; Williams, S, 2012) |
| "When myocardial infarction is due to coronary embolism from endocarditic valves standard thrombolysis regimes should be avoided." | 1.29 | Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report. ( Connolly, DL; Crowley, JJ; Dardas, PS; Kenny, A; Petch, MC, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (31.58) | 18.7374 |
| 1990's | 14 (18.42) | 18.2507 |
| 2000's | 16 (21.05) | 29.6817 |
| 2010's | 18 (23.68) | 24.3611 |
| 2020's | 4 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Granath, C | 1 |
| Freiholtz, D | 1 |
| Bredin, F | 1 |
| Olsson, C | 1 |
| Franco-Cereceda, A | 1 |
| Björck, HM | 1 |
| Ruzina, EV | 1 |
| Berdibekov, BS | 1 |
| Bulaeva, NI | 1 |
| Kubova, MC | 1 |
| Golukhova, EZ | 1 |
| Gryaznov, AA | 1 |
| Saeyeldin, A | 1 |
| Abdelbaky, M | 1 |
| Zafar, MA | 1 |
| Tanweer, M | 1 |
| Papanikolaou, D | 1 |
| Imran, M | 1 |
| Li, Y | 1 |
| Ziganshin, BA | 1 |
| Elefteriades, JA | 1 |
| Smilowitz, NR | 1 |
| Berger, JS | 1 |
| Mahajan, K | 1 |
| Negi, P | 1 |
| Merwaha, R | 1 |
| Sharma, M | 1 |
| Baumann Kreuziger, L | 1 |
| Karkouti, K | 1 |
| Tweddell, J | 1 |
| Massicotte, MP | 1 |
| Jiang, Z | 1 |
| Elkind, M | 1 |
| Lucky, M | 1 |
| Fekete, Z | 1 |
| Suri, RM | 1 |
| Thourani, VH | 1 |
| He, X | 1 |
| Brennan, JM | 1 |
| O'Brien, SM | 1 |
| Rankin, JS | 1 |
| Schaff, HV | 1 |
| Gammie, JS | 1 |
| Trenson, S | 1 |
| de Ceuninck, M | 1 |
| Riaz, H | 1 |
| Alansari, SA | 1 |
| Khan, MS | 1 |
| Riaz, T | 1 |
| Raza, S | 1 |
| Luni, FK | 1 |
| Khan, AR | 1 |
| Riaz, IB | 1 |
| Krasuski, RA | 1 |
| Windecker, S | 1 |
| Tijssen, J | 1 |
| Giustino, G | 1 |
| Guimarães, AH | 1 |
| Mehran, R | 1 |
| Valgimigli, M | 1 |
| Vranckx, P | 1 |
| Welsh, RC | 1 |
| Baber, U | 1 |
| van Es, GA | 1 |
| Wildgoose, P | 1 |
| Volkl, AA | 1 |
| Zazula, A | 1 |
| Thomitzek, K | 1 |
| Hemmrich, M | 1 |
| Dangas, GD | 1 |
| Owais, T | 1 |
| Rouman, M | 1 |
| Breuer, M | 1 |
| Hüter, L | 1 |
| Fuchs, J | 1 |
| Lauer, B | 1 |
| Kuntze, T | 1 |
| Moreno, R | 1 |
| Payanam Ramachandra, U | 1 |
| Shenoy, SJ | 1 |
| Arumugham, S | 1 |
| Salem, DN | 2 |
| O'Gara, PT | 1 |
| Madias, C | 1 |
| Pauker, SG | 2 |
| Csiba, L | 1 |
| Kovács, KR | 1 |
| Eisen, DP | 1 |
| Corey, GR | 1 |
| McBryde, ES | 1 |
| Fowler, VG | 1 |
| Miro, JM | 1 |
| Cabell, CH | 1 |
| Street, AC | 1 |
| Paiva, MG | 1 |
| Ionac, A | 1 |
| Tan, RS | 1 |
| Tribouilloy, C | 1 |
| Pachirat, O | 1 |
| Jones, SB | 1 |
| Chipigina, N | 1 |
| Naber, C | 1 |
| Pan, A | 1 |
| Ravasio, V | 1 |
| Gattringer, R | 1 |
| Chu, VH | 1 |
| Bayer, AS | 1 |
| ElBardissi, AW | 1 |
| DiBardino, DJ | 1 |
| Chen, FY | 1 |
| Yamashita, MH | 1 |
| Cohn, LH | 1 |
| Colli, A | 2 |
| D'Amico, R | 1 |
| Mestres, CA | 1 |
| Pomar, JL | 1 |
| Cámara, ML | 1 |
| Ruyra, X | 1 |
| Mulet, J | 1 |
| Gendlin, GE | 1 |
| Tronina, OA | 1 |
| Storozhakov, GI | 1 |
| Jacob, M | 1 |
| Smedira, N | 1 |
| Blackstone, E | 1 |
| Williams, S | 1 |
| Cho, L | 1 |
| Whitlock, RP | 1 |
| Sun, JC | 1 |
| Fremes, SE | 1 |
| Rubens, FD | 1 |
| Teoh, KH | 1 |
| Oliveira, LH | 1 |
| Mallmann, FB | 1 |
| Botelho, FN | 1 |
| Paul, LC | 1 |
| Gianotto, M | 1 |
| Abt, Rde B | 1 |
| Silva, NJ | 1 |
| Luize, CM | 1 |
| Nogueira, FL | 1 |
| Carvalho, RS | 1 |
| Paola, AA | 1 |
| Cirenza, C | 1 |
| Tzeng, SS | 1 |
| Liou, JT | 1 |
| Petricevic, M | 1 |
| Biocina, B | 1 |
| Gasparovic, H | 1 |
| Ivancan, V | 1 |
| Comunale, ME | 1 |
| Maslow, A | 1 |
| Robertson, LK | 1 |
| Haering, JM | 1 |
| Mashikian, JS | 1 |
| Lowenstein, E | 1 |
| CLARK, EJ | 1 |
| HOUSER, HB | 1 |
| PIERAGNOLI, E | 1 |
| CASA, G | 1 |
| ZHELEZNOVA, AI | 1 |
| Gherli, T | 1 |
| Nicolini, F | 1 |
| Stein, PD | 1 |
| Al-Ahmad, A | 1 |
| Bussey, HI | 1 |
| Horstkotte, D | 1 |
| Miller, N | 1 |
| Minola, E | 1 |
| Arosio, M | 1 |
| Rizzo, G | 1 |
| Passerini Tosi, C | 1 |
| Suter, F | 1 |
| Goglio, A | 1 |
| Vaughan, P | 1 |
| Waterworth, PD | 1 |
| García-Rinaldi, R | 1 |
| Laurent, M | 1 |
| Lelong, B | 1 |
| Lenormand, C | 1 |
| De Place, C | 1 |
| Matali, P | 1 |
| Leurent, G | 1 |
| Verhoye, JP | 1 |
| Almange, C | 1 |
| Leguerrier, A | 1 |
| Descarries, LM | 1 |
| Leduc, L | 1 |
| Khairy, P | 1 |
| Mercier, LA | 1 |
| Hori, M | 1 |
| Weinstein, GS | 1 |
| Mavroudis, C | 1 |
| Ebert, PA | 1 |
| de Boer, AC | 1 |
| Genton, E | 2 |
| Turpie, AG | 3 |
| Harris, R | 1 |
| Crowley, DC | 1 |
| Fuster, V | 3 |
| Chesebro, JH | 1 |
| Warlow, CP | 1 |
| Toyohira, H | 1 |
| Nakamura, K | 1 |
| Kariyazono, H | 1 |
| Yamada, K | 1 |
| Moriyama, Y | 1 |
| Shimokawa, S | 1 |
| Saigenji, H | 1 |
| Taira, A | 1 |
| Yankah, AC | 1 |
| Alexi-Meskhishvili, V | 1 |
| Weng, Y | 1 |
| Berger, F | 1 |
| Lange, P | 1 |
| Hetzer, R | 1 |
| Yamak, B | 1 |
| Sener, E | 1 |
| Kiziltepes, U | 1 |
| Gol, K | 1 |
| Tarcan, O | 1 |
| Mavitas, B | 1 |
| Tasdemir, O | 1 |
| Bayazit, K | 1 |
| Connolly, DL | 1 |
| Dardas, PS | 1 |
| Crowley, JJ | 1 |
| Kenny, A | 1 |
| Petch, MC | 1 |
| Asherson, RA | 1 |
| Cervera, R | 1 |
| Albertal, J | 1 |
| Sutton, M | 1 |
| Pereyra, D | 1 |
| Segura, EV | 1 |
| Aramburu, DF | 1 |
| Lardani, H | 1 |
| Diaz, R | 1 |
| Malaterre, HR | 1 |
| Daver, L | 1 |
| Djiane, P | 1 |
| Boon, A | 1 |
| Lodder, J | 1 |
| Cheriex, E | 1 |
| Kessels, F | 1 |
| Gershlick, AH | 1 |
| Manning, WJ | 1 |
| Goldsmith, I | 1 |
| Lip, GY | 1 |
| Mukundan, S | 1 |
| Rosin, MD | 1 |
| Laffort, P | 1 |
| Roudaut, R | 1 |
| Roques, X | 1 |
| Lafitte, S | 1 |
| Deville, C | 1 |
| Bonnet, J | 1 |
| Baudet, E | 1 |
| Rowan, JA | 1 |
| McCowan, LM | 1 |
| Raudkivi, PJ | 1 |
| North, RA | 1 |
| Prisco, D | 1 |
| Salazar Mena, J | 1 |
| García Moya, JB | 1 |
| Felipe Villaverde, J | 1 |
| García de la Calzada, MD | 1 |
| Didisheim, P | 2 |
| Hirsh, J | 2 |
| Trufanova, AV | 1 |
| Kuz'mina, NN | 1 |
| Glazkova, TG | 1 |
| Dale, J | 2 |
| Myhre, E | 1 |
| Reich, DL | 1 |
| Hammerschlag, BC | 1 |
| Rand, JH | 1 |
| Perucho-Powell, MH | 1 |
| Thys, DM | 1 |
| Koenig, A | 1 |
| Théolade, R | 1 |
| Chauvin, M | 1 |
| Brechenmacher, C | 1 |
| Toshima, H | 1 |
| Tanabe, A | 1 |
| Deans, KW | 1 |
| Hartshorn, JC | 1 |
| Nuñez, L | 1 |
| Pinto, AG | 1 |
| Larrea, JL | 1 |
| Gil Aguado, M | 1 |
| Connor, FO | 1 |
| Nitter-Hauge, S | 1 |
| Kingdon, HS | 1 |
| Isom, OW | 1 |
| Williams, CD | 1 |
| Falk, EA | 1 |
| Spencer, FC | 1 |
| Glassman, E | 1 |
| Tahernia, AC | 1 |
| Moatamed, F | 1 |
| Sharif, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| REACTIC-TAVI Trial: Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation. A Pilot Study.[NCT04331145] | Phase 4 | 40 participants (Actual) | Interventional | 2020-06-23 | Completed | ||
| Global Multicenter, Open-label, Randomized, Event-driven, Active-controlled Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement (TAVR) to Optimize Clinical Outcomes[NCT02556203] | Phase 3 | 1,653 participants (Actual) | Interventional | 2015-12-16 | Terminated (stopped due to Imbalance in the efficacy and safety endpoints between treatment arms in favor of comparator) | ||
| Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement[NCT01293188] | 434 participants (Actual) | Observational | 2011-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Composite of CV-death, any stroke, myocardial infarction (MI), symptomatic valve thrombosis, pulmonary embolism (PE), deep vein thrombosis (DVT), and non-central nervous system (CNS) systemic embolism (per adjudication). (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 83 |
| Antiplatelet | 68 |
Composite of BARC 2,3 or 5 bleedings (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 148 |
| Antiplatelet | 85 |
Death or first adjudicated thromboembolic event (DTE), defined as composite of all-cause death, any stroke, myocardial infarction (MI), symptomatic valve thrombosis, pulmonary embolism (PE), deep vein thrombosis (DVT), and non-central nervous system (CNS) systemic embolism. (NCT02556203)
Timeframe: Through study completion, on average 14 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 68 |
| Antiplatelet | 63 |
Death or first adjudicated thromboembolic event (DTE), defined as composite of all-cause death, any stroke, myocardial infarction (MI), symptomatic valve thrombosis, pulmonary embolism (PE), deep vein thrombosis (DVT), and non-central nervous system (CNS) systemic embolism. (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 105 |
| Antiplatelet | 78 |
ISTH major bleeds (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 49 |
| Antiplatelet | 30 |
The net-clinical-benefit defined as the adjudicated composite of all-cause death, any stroke, myocardial infarction, symptomatic valve thrombosis, pulmonary embolism, deep vein thrombosis, non-CNS systemic embolism (efficacy); VARC life-threatening, disabling and VARC major bleeds (safety). (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 137 |
| Antiplatelet | 100 |
PBE is defined according to VARC (Valve Academic Research Consortium) definitions as the adjudicated composite of: Life-threatening, disabling or major bleeding. (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 46 |
| Antiplatelet | 31 |
Composite of TIMI major and minor bleedings (NCT02556203)
Timeframe: Through study completion, on average 16 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rivaroxaban (Xarelto, BAY59-7939) | 42 |
| Antiplatelet | 24 |
21 reviews available for aspirin and Heart Valve Diseases
| Article | Year |
|---|---|
Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagul | 2020 |
Antithrombotic therapy management of adult and pediatric cardiac surgery patients.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Blood Coagulation; Cardiac Surgical Procedures; Cardiolo | 2018 |
Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Drug Administration Schedule; Heart Valve Dise | 2016 |
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Heart Valve Diseases; Humans; Postoperative Complicati | 2017 |
[Antithrombotic therapy in primary and secondary stroke prevention of cardiac patients and in acute stroke].
Topics: Acute Disease; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Fibrinoly | 2009 |
[Antithrombotic therapy in patients with prosthetic heart valves].
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Drug Monitoring; Heart Valve Diseases | 2010 |
Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Aspirin; Bioprosthesis; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Diseases; Heart Va | 2004 |
[Primary and secondary prevention of cardiogenic cerebral embolism].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Heart Valve Diseases; Humans; Intracrani | 2006 |
Chemistry, measurement, and clinical significance of platelet specific proteins.
Topics: Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Factors; Blood P | 1982 |
Cardiovascular diseases in the elderly.
Topics: Aged; Aging; Amyloidosis; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Brain Ischemia; Car | 1983 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Cerebrovascular disease.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Platelets; Cerebrovascular Disorders; Fibrin | 1981 |
Cardiac manifestations of the antiphospholipid syndrome.
Topics: Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Coronary Disease; H | 1993 |
Treating the non-electrical risks of atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Heart Valve Diseases; | 1997 |
Role of transesophageal echocardiography in the management of thromboembolic stroke.
Topics: Anticoagulants; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Aspirin; Cerebrovascular Disorde | 1997 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Dis | 1978 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease | 1978 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
Cardiac thromboembolism: evidence for role of platelets and value of platelet suppressant therapy.
Topics: Aspirin; Blood Platelets; Cell Survival; Clofibrate; Coronary Disease; Heart Diseases; Heart Valve D | 1978 |
[Embolic complications of chronic atrial fibrillation].
Topics: Aspirin; Atrial Fibrillation; Chronic Disease; Heart Valve Diseases; Humans; Primary Prevention; Pro | 1992 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
8 trials available for aspirin and Heart Valve Diseases
| Article | Year |
|---|---|
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, | 2017 |
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, | 2017 |
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, | 2017 |
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, | 2017 |
Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Cardiopulmonary Bypass; Constriction, Pathol | 2003 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1981 |
[Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
Topics: Adult; Aged; Anticoagulants; Aspirin; Blood Coagulation; Depression, Chemical; Drug Therapy, Combina | 1995 |
Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study.
Topics: Administration, Oral; Anticoagulants; Aspirin; Drug Therapy, Combination; Echocardiography, Transeso | 2000 |
[Prevention of arterial embolism by acetylsalicyclic acid and anticoagulants in patients with heart valve prosthesis].
Topics: Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Embolism; | 1976 |
Modest doses of nitroglycerin do not interfere with beef lung heparin anticoagulation in patients taking nitrates.
Topics: Adult; Anticoagulants; Aspirin; Drug Administration Schedule; Drug Interactions; Heart Valve Disease | 1992 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
48 other studies available for aspirin and Heart Valve Diseases
| Article | Year |
|---|---|
Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2.
Topics: Aorta; Aortic Aneurysm; Aspirin; Cross-Sectional Studies; Cyclooxygenase 2; Heart Valve Diseases; Hu | 2022 |
[Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Female; Fibrinolytic Agents; Heart Va | 2023 |
Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aortic Valve Insufficiency; Aortic Val | 2020 |
Isolated tricuspid valve Libman-Sacks endocarditis in a patient with antiphospholipid antibody syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Echocardiography; Endocarditis; Female; H | 2017 |
Stroke in a young man: a late complication of radiation therapy.
Topics: Adult; Anticholesteremic Agents; Aortic Valve; Aspirin; Echocardiography, Transesophageal; Factor Xa | 2019 |
Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted?
Topics: Aged; Anticoagulants; Aspirin; Cohort Studies; Confidence Intervals; Databases, Factual; Female; Fol | 2013 |
A calcified left ventricular mass.
Topics: Aged, 80 and over; Aging; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; At | 2014 |
Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
Topics: Aged; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Blood Coagulation; Brain Ischemia; Femal | 2016 |
Improved Pig Model to Evaluate Heart Valve Thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Disease Models, Animal; Heart Val | 2016 |
Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Aspirin; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Diseases; Humans; Platelet Aggreg | 2008 |
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid.
Topics: Aged; Aspirin; Cohort Studies; Embolism; Endocarditis, Bacterial; Female; Heart Failure; Heart Valve | 2009 |
Testing a no-warfarin heart valve.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet | 2006 |
Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Chi-Square Distribution; Drug Adminis | 2010 |
Is early antithrombotic therapy necessary after tissue mitral valve replacement?
Topics: Aged; Aged, 80 and over; Animals; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Cattle; Ch | 2010 |
Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery.
Topics: Aged; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Female; Fibrinolytic Agents; Follow- | 2012 |
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Aspirin; Catheterization; Combined Modality Therapy; Ductus Arteriosus, Patent; Evidence-Based Medic | 2012 |
Cross-sectional study of treatment strategies on atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrilla | 2012 |
Bead-like coronary spasm.
Topics: Aspirin; Bradycardia; Calcium Channel Blockers; Chest Pain; Coronary Angiography; Coronary Stenosis; | 2012 |
Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery.
Topics: Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Female; Heart Valve Diseases; Heart Valve | 2012 |
Comparative effects of 3-hydroxy-2-phenylcinchoninic acid (HPC) and aspirin on the acute course of rheumatic fever and the occurrence of rheumatic valvular disease.
Topics: Aspirin; Heart Valve Diseases; Humans; Quinolines; Rheumatic Fever; Rheumatic Heart Disease | 1953 |
[Effect of adrenocortical hormones, antirheumatic drugs and histaminics on experimental valvulitis and myocarditis caused by O-streptolysin].
Topics: Anti-Allergic Agents; Antirheumatic Agents; Aspirin; Bacterial Proteins; Cortisone; Desoxycorticoste | 1956 |
[REMOTE RESULTS OF HORMONE THERAPY OF RHEUMATIC CHILDREN].
Topics: Adolescent; Aminopyrine; Arthritis; Arthritis, Rheumatoid; Aspirin; Child; Cortisone; Drug Therapy; | 1963 |
Incidence of anticoagulation in patients with bioprostheses.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Follow-Up Studies; Heart Valve Diseases; Heart | 2004 |
Clinical and laboratory features of acute rheumatic fever: a 18-year experience.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aspirin; Child; Echocardiography; E | 2005 |
An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
Topics: Adult; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Consultants; Fibrinolytic Agents; Guide | 2005 |
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Sel | 2006 |
[Early non-obstructive thrombosis of mechanical mitral valve prostheses].
Topics: Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Echocardiography, Transesophageal; | 2005 |
Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Biomarkers; Coronary Artery D | 2006 |
Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Child; Child, Preschool; Dicumarol | 1982 |
Cardiovascular complications of mucocutaneous lymph node syndrome.
Topics: Aneurysm; Aspirin; Child, Preschool; Coronary Disease; Echocardiography; Female; Heart Diseases; Hea | 1984 |
Performance of aortic and pulmonary homografts in the right ventricular outflow tract in children.
Topics: Age Factors; Aortic Valve; Aortic Valve Stenosis; Aspirin; Calcinosis; Cardiac Catheterization; Chil | 1995 |
Low dose anticoagulation after St. Jude Medical prosthesis implantation in patients under 18 years of age.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; | 1995 |
Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report.
Topics: Aortic Valve; Aspirin; Embolism; Endocarditis, Bacterial; Gastrointestinal Hemorrhage; Heart Valve D | 1994 |
Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
Topics: Acenocoumarol; Adult; Aged; Aspirin; Blood Coagulation Tests; Dose-Response Relationship, Drug; Drug | 1993 |
[Myocardial infarction and cerebrovascular accident complicating papillary elastofibroma of the mitral valve].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Fibroma; Heart Neoplasms; He | 1995 |
Risk of stroke in a cohort of 815 patients with calcification of the aortic valve with or without stenosis.
Topics: Age Factors; Aged; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Aspirin; Calcinosis; Cause o | 1996 |
Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Data Collection; Dose-Response Relati | 1998 |
Enoxaparin treatment in women with mechanical heart valves during pregnancy.
Topics: Adult; Antibodies; Anticoagulants; Aspirin; Enoxaparin; Factor Xa; Female; Heart Valve Diseases; Hea | 2001 |
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Diabetes | 2001 |
[Acute rheumatic carditis. Follow-up (author's transl)].
Topics: Acute Disease; Adrenal Cortex Hormones; Aspirin; Cardiomegaly; Child; Child, Preschool; Endocarditis | 1979 |
[New approaches to selection of an optimal method of treatment of children with rheumatic valvulitis on the basis of a prognostic table obtained with the aid of a computer].
Topics: Aortic Valve; Aspirin; Child; Computers; Drug Evaluation; Female; Heart Valve Diseases; Humans; Male | 1979 |
[Valvular heart disease].
Topics: Aortic Valve; Arrhythmias, Cardiac; Aspirin; Digitalis; Echocardiography; Electrocardiography, Ambul | 1991 |
Use of antithrombotic agents in valvular heart disease.
Topics: Aspirin; Dipyridamole; Heart Valve Diseases; Humans; Patient Education as Topic; Warfarin | 1987 |
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therap | 1986 |
Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination | 1986 |
Anticoagulants: a guide for practitioners.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Dicumarol; Disseminated Intravascular Coagulation; Electri | 1973 |
Evaluation of anticoagulant therapy in cloth-covered prosthetic valves.
Topics: Anticoagulants; Aortic Valve; Aspirin; Cerebral Hemorrhage; Heart Valve Diseases; Heart Valve Prosth | 1973 |
Some clinical observations on rheumatic fever in childhood. Patterns of the disease as seen in Southern iran.
Topics: Adolescent; Aspirin; Blood Sedimentation; Child; Child, Preschool; Chorea; Electrocardiography; Endo | 1971 |